Consensus document on improving hypertension management in asian patients, taking into account asian characteristics

Kazuomi Kario, Chen Huan Chen, Sungha Park, Chang Gyu Park, Satoshi Hoshide, Hao Min Cheng, Qi Fang Huang, Ji Guang Wang

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)
Original languageEnglish
Pages (from-to)375-382
Number of pages8
Issue number3
Publication statusPublished - 2018

Bibliographical note

Funding Information:
J.-G. Wang received lecture and consulting fees from Bayer, Daiichi Sankyo, MSD, Pfizer, Sanofi, Servier, and Takeda. K. Kario received research funding from Teijin Pharma Limited, Omron Healthcare Co., Ltd., Fukuda Denshi, Bayer Yakuhin Ltd., A &D Co., Ltd., Daiichi Sankyo Company, Limited, Mochida Pharmaceutical Co., Ltd, EA Pharma, Boehringer Ingelheim Japan Inc, Tanabe Mitsubishi Pharma Corporation, Shionogi & Co., Ltd., MSD K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Bristol-Myers Squibb K.K., and honoraria from Takeda Pharmaceutical Company Limited and Omron Healthcare Co., Ltd. The other authors report no conflicts.

Funding Information:
The meetings held between the authors to discuss and prepare this manuscript were funded by an unrestricted educational grant from Daiichi Sankyo Co. Ltd.

Funding Information:
We acknowledge Dr Cathy Chow (Calico Communications) for editorial support, which was funded by Daiichi Sankyo Co. Ltd, and Haruo Anzai (Daiichi Sankyo Co. Ltd.) and Mitsunori Sugiyama (Daiichi Sankyo Co. Ltd.) for their logistical support.

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this